Privia Health Group, Inc. (NASDAQ:PRVA) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have earned a consensus rating of “Moderate Buy” from the fifteen ratings firms that are presently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $30.4167.

A number of brokerages recently weighed in on PRVA. Evercore ISI lifted their price objective on shares of Privia Health Group from $28.00 to $30.00 and gave the company an “outperform” rating in a report on Friday, November 7th. JPMorgan Chase & Co. boosted their price target on shares of Privia Health Group from $32.00 to $33.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Stephens reiterated an “overweight” rating and issued a $32.00 price objective on shares of Privia Health Group in a research note on Thursday, December 4th. Barclays lifted their target price on Privia Health Group from $22.00 to $23.00 and gave the company an “equal weight” rating in a report on Monday, November 10th. Finally, Truist Financial restated a “buy” rating and set a $31.00 price target (up previously from $30.00) on shares of Privia Health Group in a report on Monday, November 10th.

Insider Activity at Privia Health Group

In other news, Director Matthew Shawn Morris sold 13,647 shares of the firm’s stock in a transaction on Friday, December 12th. The shares were sold at an average price of $25.01, for a total value of $341,311.47. Following the sale, the director directly owned 68,188 shares in the company, valued at approximately $1,705,381.88. This trade represents a 16.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO David Mountcastle sold 23,887 shares of Privia Health Group stock in a transaction on Friday, December 12th. The stock was sold at an average price of $25.03, for a total transaction of $597,891.61. Following the sale, the chief financial officer directly owned 172,909 shares of the company’s stock, valued at approximately $4,327,912.27. This trade represents a 12.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 10.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On Privia Health Group

Large investors have recently bought and sold shares of the business. Russell Investments Group Ltd. lifted its holdings in Privia Health Group by 2,852.2% during the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock worth $60,000 after buying an additional 2,567 shares during the last quarter. Northern Trust Corp raised its position in shares of Privia Health Group by 2.2% during the 1st quarter. Northern Trust Corp now owns 1,423,865 shares of the company’s stock worth $31,966,000 after acquiring an additional 31,224 shares in the last quarter. Hsbc Holdings PLC lifted its stake in Privia Health Group by 55.5% during the first quarter. Hsbc Holdings PLC now owns 67,192 shares of the company’s stock worth $1,493,000 after purchasing an additional 23,983 shares during the last quarter. Smartleaf Asset Management LLC lifted its stake in Privia Health Group by 24.5% during the first quarter. Smartleaf Asset Management LLC now owns 9,060 shares of the company’s stock worth $205,000 after purchasing an additional 1,785 shares during the last quarter. Finally, Epoch Investment Partners Inc. acquired a new position in Privia Health Group in the first quarter valued at approximately $922,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Up 1.9%

PRVA opened at $24.13 on Wednesday. Privia Health Group has a 52 week low of $18.77 and a 52 week high of $26.51. The business has a fifty day simple moving average of $24.32 and a 200-day simple moving average of $22.86. The firm has a market cap of $2.97 billion, a P/E ratio of 185.63, a P/E/G ratio of 4.11 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last posted its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%.The firm had revenue of $213.61 million for the quarter. Sell-side analysts expect that Privia Health Group will post 0.14 earnings per share for the current year.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.